Stem Cell Agency May Loan Out $500M
Decisions about the program's size, goals and structure remain to be
made. The agency said it is still deciding whether to run the loan
program in-house or pick outside delegated underwriters and how much to
lend in total. And still unresolved is whether the program is intended
as a loss-leading driver of innovation in a commercially risky field or
more of a way to help bolster CIRM's budget by generating loan-related
income, said John M. Simpson, director of the stem cell project at the
advocacy group Consumer Watchdog.<br />
